Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Clin Cancer Res. 2016 Dec 8;23(5):1132–1136. doi: 10.1158/1078-0432.CCR-16-0968

Figure 2.

Figure 2

The necrosome may herald an exciting new era in cancer therapy. There is ample rationale for potential synergistic efficacy of targeting the necrosome in combination with available check-point-directed immunotherapy